alexa Elucidation Of Small Molecule Markers In Cancer Cells By NMR And Mass Spectrometry | 10203
ISSN: 2155-9872

Journal of Analytical & Bioanalytical Techniques
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Share This Page

Elucidation of small molecule markers in cancer cells by NMR and mass spectrometry

4th International Conference and Exhibition on Analytical & Bioanalytical Techniques

Greg Heffron

ScientificTracks Abstracts: J Anal Bioanal Tech

DOI: 10.4172/2155-9872.S1.013

Abstract
Metabolic signatures of cell transformation in various cancers are of keen interest in gaining a better understanding of how oncogenes and proteins are expressed, and may potentially aid in the identification of suitable targets for therapeutic interventions. A platform based primarily on NMR spectroscopy that allows a relatively straightforward investigation of altered metabolite levels in cell extracts or other biological fluids will be presented and discussed. Application of the proposed methods to several types of cancer cells will also be presented, with an emphasis on identification of potentially interesting bio-markers. An example of pathway analysis and marker validation will provide a possible link between observed metabolite levels and genetic modifications in a cell model of chronic myelogenous leukemia.
Biography
Greg Heffron did his undergraduate study in Chemistry at LeMoyne College and graduate studies in biophysics at Syracuse University. His main interests include studies of differential metabolite levels in cancer cells by NMR spectroscopy. He is currently the Director of the Bio-molecular NMR facility at Harvard Medical School.
Top